Volume 73, Issue 10, Pages (May 2008)

Slides:

Advertisements

Similar presentations

Diabetic Retinopathy (DR) Ayesha S Abdullah

Advertisements

Hereditary Angioedema

Melamine toxicity: one more culprit in calcium kidney lithiasis

Nat. Rev. Nephrol. doi: /nrneph

Ahmad Shihada Silmi Msc, FIBMS IUG Medical Lab. sciences Dept

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Volume 78, Issue 2, Pages (July 2010)

Viper venom for diabetic nephropathy

Frederic Rahbari-Oskoui, MD, MS American Journal of Kidney Diseases

Bettina Haslinger-Löffler Kidney International

Correction The Journal of Allergy and Clinical Immunology: In Practice

Shining light on vitamin D trials in chronic kidney disease

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

The kallikrein–kinin system in health and in diseases of the kidney

The kallikrein–kinin system in diabetic nephropathy

Volume 77, Issue 1, Pages 6-8 (January 2010)

Volume 81, Issue 4, Pages (February 2012)

Propofol as a panacea for acute kidney injury?

Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels Kusumam Joseph, PhD,

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Volume 85, Issue 3, Pages (March 2014)

Volume 80, Issue 9, Pages (November 2011)

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Angioedema and estrogen-dependent angioedema with activation of the contact system François Hentges, MD, Christiane Hilger, PhD, Marianne Kohnen, BSc,

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 86, Issue 2, Pages (August 2014)

Hark Rim, Ho S. Shin, Yeon S. Jung

Thomas Quaschning, Jan Galle, Christoph Wanner

Volume 80, Issue 8, Pages (October 2011)

Melamine toxicity: one more culprit in calcium kidney lithiasis

Volume 82, Issue 1, Pages 3-4 (July 2012)

David M. Charytan, John P. Forman Kidney International

Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen David I. Ortiz-Melo, Robert F. Spurney

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 85, Issue 5, Pages (May 2014)

The future of renoprotection: Frustration and promises

Volume 74, Issue 8, Pages (October 2008)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Calcium sensing in podocytes

Pathways for bradykinin formation and inflammatory disease

Volume 53, Issue 4, Pages (April 1998)

Nephrology Crossword: Glomerulonephritis

Hydrogen: another gas with therapeutic potential

Circadian regulation of renal function

Volume 73, Issue 9, Pages (May 2008)

Karen A. Griffin, Anil K. Bidani Kidney International

Volume 82, Issue 9, Pages (November 2012)

Volume 73, Issue 5, Pages (March 2008)

Volume 63, Issue 4, Pages (April 2003)

Volume 83, Issue 5, Pages (May 2013)

Volume 76, Issue 1, Pages 8-10 (July 2009)

Is complement a target for therapy in renal disease?

Volume 71, Issue 9, Pages (May 2007)

Kathryn J. Wiggins, Darren J. Kelly Kidney International

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Volume 75, Issue 7, Pages (April 2009)

Erratum Kidney International Volume 61, Issue 4, (April 2002)

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications

Angiotensin I-Converting Enzyme

Hisataka Kobayashi, Peter L. Choyke Kidney International

The international realities of live donor kidney transplantation

Volume 75, Issue 8, Pages (April 2009)

Proteinuria and hypertension with tyrosine kinase inhibitors

The Ebf1 knockout mouse and glomerular maturation

Presentation transcript:

Volume 73, Issue 10, Pages 1114-1119 (May 2008) The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney J.A. Phipps, E.P. Feener Kidney International Volume 73, Issue 10, Pages 1114-1119 (May 2008) DOI: 10.1038/ki.2008.9 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 The kallikrein–kinin system. The pathways involved in the kallikrein–kinin and contact systems. A2M, α-2-macroglobulin; ACE, angiotensin-converting enzyme; B1-rec, bradykinin 1 receptor; B2-rec, bradykinin 2 receptor; C1-INH, complement 1 inhibitor; FXII, factor XII; FXIIa, factor XIIa; HK, high-molecular-weight kininogen; LK, low-molecular-weight kininogen; NEP, neural endopeptidase 24.11. Kidney International 2008 73, 1114-1119DOI: (10.1038/ki.2008.9) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Potential interactions of the KKS in diabetic retinopathy. Schematic of the retinal fundus illustrating the potential involvement of the components of the KKS found in the vitreous in diabetic retinopathy changes. Red lines indicate arteries and blue lines indicate veins. FXII, factor XII; FXIIa, factor XIIa; HK, high-molecular-weight kininogen; Kal, kallikrein; PK, prekallikrein; KKS, kallikrein–kinin system. Kidney International 2008 73, 1114-1119DOI: (10.1038/ki.2008.9) Copyright © 2008 International Society of Nephrology Terms and Conditions